Fatty acid synthase: A novel target for antiglioma therapy

British Journal of Cancer

Volumn 95, Issue 7, 2006, Pages 869-878

  Zhao, W ^a   Kridel, S ^a   Thorburn, A ^a   Kooshki, M ^a   Little, J ^a   Hebbar, S ^a   Robbins, M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2; Cell cycle arrest; Cerulenin; Fatty acid synthase; Glioma cells

Indexed keywords

CERULENIN; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME DEGRADATION; FATTY ACID SYNTHESIS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; ASTROCYTES; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CERULENIN; COLLAGEN TYPE XI; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FATTY ACID SYNTHETASE COMPLEX; FLOW CYTOMETRY; GLIOMA; HUMANS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RATS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 33749329775     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603350     Document Type: Article

References (57)

1. Akao Y, Otsuki Y, Kataoka S, Ito Y, Tsujimoto Y (1994) Multiple subcellular localization of bcl-2: detection in nuclear outermembrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res 54: 2468-2471
2. Amant F, Lottering ML, Joubert A, Thaver V, Vergote I, Lindeque BG (2003) 2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth. Gynecol Oncol 91: 299-308
3. Bansal K, Engelhard HH (2000) Gene therapy for brain tumors. Curr Oncol 2: 463-472
4. Berger NA, Sims JL, Catino DM, Berger SJ (1983) In ADP-ribosylation, DNA Repair and Cancer. Miwa M, Hayaishi O, Shall S, Smulson M, Sugimura T (eds) pp. 219-226. Japan Scientific Society Press: Tokyo
5. De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV (2003) RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res 63: 3799-3804
6. Epstein JI, Carmichael M, Partin AW (1995) OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 45: 81-86
7. Funabashi H, Kawaguchi A, Tomoda H, Omura S, Okuda S, Iwasaki S (1989) Binding site of cerulenin in fatty acid synthetase. J Biochem 105: 751-755
8. Furuya Y, Akimoto S, Yasada K, Ito H (1997) Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. Anticancer Res 17: 4589-4593
9. Gabrielson EW, Pinn ML, Testa JR, Kuhajda FP (2001) Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res 7: 153-157
10. Gansler TS, Hardman III W, Hunt DA, Schaffel S, Hennigar RA (1997) Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28: 686-692
11. Garbay B, Bauxis-Lagrave S, Boiron-Sargueil F, Elson G, Cassagne C (1997) Acetyl-CoA carboxylase gene expression in the developing mouse brain. Comparison with other genes involved in lipid biosynthesis. Dev Brain Res 98: 197-203
12. Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Lephart A, Pherai DS, Haisma HJ, Pinedo HM, Curiel DT, Gerritsen WR (2001) Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin Cancer Res 7: 641-650
13. Griscelli F, Li H, Cheong C, Opolon P, Bennaceur-Griscelli A, Vassal G, Soria J, Soria, C, Lu H, Perricaudet M, Yeh P (2000) Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci USA 97: 6698-6703
14. Heiligtag SJ, Bredehorst R, David KA (2002) Key role of mitochondria in cerulenin-mediated apoptosis. Cell Death Differ 9: 1017-1025
15. Huang PL, Zhu SN, Lu SL, Dai ZS, Jin YL (2000) Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World J Gastroenterol 6: 295-297
16. Jackowski S (1994) Coordination of membrane phospholipid synthesis with the cell cycle. J Biol Chem 269: 3858-3867
17. Jackowski S, Wang J, Baburina I (2000) Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells. Biochim Biophys Acta 1483: 301-315
18. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130
19. Karpati G, Nalbantoglu J (2003) The principles of molecular therapies for glioblastoma. Int Rev Neurobiol 55: 151-163
20. Kew Y, Levin VA (2003) Advances in gene therapy and immunotherapy for brain tumors. Curr Opin Neurol 16: 665-670
21. Kridel SJ, Axelrod F, Rosenkrantz N, Smith JW (2004) Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 64: 2070-2075
22. Kuhajda FP (2006) Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 66: 5977-5980
23. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 97: 3450-3454
24. Kusakabe T, Maeda M, Hoshi N, Sugino T, Watanabe K, Fukuda T, Suzuki T (2000) Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem 48: 613-622
25. Kusakabe T, Nashimoto A, Honma K, Suzuki T (2002) Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 40: 71-79
26. Lang FF, Yung WK, Sawaya R, Tofilon PJ (1999) Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery 45: 1093-1104
27. Li J-N, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, Pizer ES (2001) Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 61: 1493-1499
28. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP (1997) Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 3: 2115-2120
29. Murphy S (1990) Generation of astrocyte cultures from normal and neoplastic central nervous system. In Methods in Neuroscience Conn PM (ed.) pp. 33-47. New York: Academic Press
30. Muse ED, Jurevics A, Toews AD, Matsushima GK, Morell P (2001) Parameters related to lipid metabolism as markers of myelination in mouse brain. J Neurochem 76: 77-86
31. Omura S (1976) The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bact Rev 40: 681-697
32. Ookhtens M, Kannan R, Lyon I, Baker, N (1984) Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol 247: R146-R153
33. Pawlik TM, Keyomarsi K (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942
34. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC, Grizzle WE (2000) The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 131: 1068-1073
35. Pizer ES, Chrest FJ, DiGiuseppe JA (1998a) Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58: 4611-4615
36. Pizer ES, Lax S, Kuhajda FP, Pasternak GR, Kurman RJ (1998b) Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 83: 528-537
37. Pizer ES, Pflug BR, Bova GS, Han WF, Udan MS, Nelson JB (2001) Increased fatty acid synthase as a therapeutic target in androgen independent prostate cancer progression. Prostate 47: 102-110
38. Pizer ES, Thupari J, Han WF, Pinn ML, Chrest FJ, Frehywot GL, Townsend CA, Kuhajda FP (2000) Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 60: 213-218
39. Pizer ES, Wood FD, Pasternack GR, Kuhajda FP (1996) Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res 56: 745-751
40. Rashid A, Pizer ES, Mog, M, Witters LA, Shy M, Jiang H, Cassagne C, Garbay B (1997) Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150: 201-208
41. Salles J, Sargueil F, Knoll-Gellida A, Witters LA, Shy M, Jaing H, Cassagne C, Garbay B (2002) Fatty acid synthase expression during peripheral nervous system myelination. Mol Brain Res 101: 52-59
42. Slade RF, Hunt DA, Pochet MM, Venema VJ, Hennigar RA (2003) Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines. Anticancer Res 23: 1235-1243
43. Spence AM, Coates PW (1978) Scanning electron microscopy of cloned astrocytic cell lines derived from ethyl nitrosourea-induced rat gliomas. Virchows Archiv [B] Cell Pathol 28: 77-85
44. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996
45. Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L, Heyns W, Verhoeven G (2002) Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 98: 19-22
46. Thupari JN, Pinn ML, Kuhajda FP (2001) Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem Biophys Res Commun 285: 217-223
47. Vartak S, McCaw R, Davis CS, Robbins ME, Spector AA (1998) γ-Linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not to normal rat astrocytes. Br J Cancer 77: 1613-1620
48. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442
49. Vlad LD, Axiotis C, Merino MJ, Green W (1999) Fatty acid synthase is highly expressed in aggressive thyroid tumors. Mod Pathol 12: 70A
50. Wakil SJ (1989) Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28: 4523-4530
51. Wang NS, Unkila MT, Reineks EZ, Distelhorst CW (2001a) Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death. J Biol Chem 276: 44117-44128
52. Wang Y, Kuhajda FP, Li JN, Pizer ES, Han WF, Sokoll LJ, Chan DW (2001b) Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett 167: 99-104
53. Weiss WA (2000) Genetics of brain tumor. Curr Opin Pediat 12: 543-548
54. Weiss L, Hoffmann GE, Schreiber R, Andres H, Fuchs E, Korber E, Kohl HJ (1986) Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler 367: 905-912
55. Zamore PD, Tuschl T, Sharp PA, Bartel, DP (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101: 25-33
56. Zhao W, Spitz DR, Oberley LW, Robbins MEC (2001) Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1. Cancer Res 61: 5537-5543
57. Zhou W, Simpson PJ, McFadden JM, Townsend CA, Medghalchi SM, Vadlamudi A, Pinn ML, Ronnett GV, Kuhjada FP (2003) Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res 63: 7330-7337